Culver City, CA, United States of America

Thomas H King

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents. Top assignees: Immunitybio, Inc., Nantbio, Inc., Nantcell, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas H King. Retrieved from https://idiyas.com/inventor/thomas-h-king-y3jgytq9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas H. King: Innovator in COVID-19 Treatment

Introduction

Thomas H. King is a notable inventor based in Culver City, California. He has made significant contributions to the field of medical research, particularly in the treatment of COVID-19. His innovative approach focuses on utilizing replication-defective adenoviruses to combat the virus effectively.

Latest Patents

Thomas H. King holds a patent for "Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein." This patent presents compositions and methods aimed at the prevention and treatment of coronavirus disease. The composition includes a recombinant entity that encodes a nucleocapsid protein of coronavirus 2 (CoV2) and/or a spike protein of CoV2.

Career Highlights

King is currently associated with Nantcell, Inc., where he continues to work on groundbreaking research in the field of virology. His dedication to developing effective treatments for viral infections has positioned him as a key figure in the medical research community.

Collaborations

One of his notable collaborators is Kayvan R. Niazi, with whom he has worked closely on various projects related to COVID-19 treatment.

Conclusion

Thomas H. King is a pioneering inventor whose work in developing treatments for COVID-19 showcases his commitment to advancing medical science. His innovative patent reflects the potential for new therapeutic strategies in combating viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…